Freedom Line Blog

As we’ve highlighted, the dangerous effort to weaken critical patent protections for U.S. pharmaceutical innovators often minimizes the role of private investment and exaggerates the role of public funding.  This offers a critical corrective at a moment when American drug and vaccine innovation is more important than ever:

The Critical Role of Private Pharmaceutical Investment

As Congress considers the so-called “Clean Future Act,” which would unfairly allow utilities to pass the cost of electric vehicle charging stations that overwhelmingly benefit the rich to all utility customers, it’s worth highlighting how even the New York Times acknowledges how impossible “Green New Deal” dreams for EVs really are:

Impossible Electric Vehicle Dreams